Results 161 to 170 of about 14,309 (181)

Diffuse inflammatory lesions in patients treated with interferon alfa and ribavirin for hepatitis C: a series of 20 patients

British Journal of Dermatology, 2002
Olivier Dereure
exaly  

Interferon alfa-2b.

2011
openaire   +1 more source

A phase 2 study to evaluate the antiviral activity, safety, and pharmacokinetics of recombinant human albumin-interferon alfa fusion protein in genotype 1 chronic hepatitis C patients

Journal of Hepatology, 2006
G Mani Subramanian, E Jenny Heathcote
exaly  

The efficacy and safety of adjuvant interferon-alfa therapy in the evolving treatment landscape for resected high-risk melanoma

Expert Opinion on Drug Safety, 2017
Wen-Jen Hwu, Van Anh Trinh
exaly  

A phase I study of subcutaneous recombinant interleukin-2 and interferon alfa-2a

Cancer, 1993
L Janisch, N J Vogelzang
exaly  

Albinterferon Alfa-2b Was Not Inferior to Pegylated Interferon-α in a Randomized Trial of Patients With Chronic Hepatitis C Virus Genotype 2 or 3

Gastroenterology, 2010
Robert Flisiak, Erik Pulkstenis, Maribel Rodriguez-Torres   +2 more
exaly  

Interferon Alfa-2b

2018
openaire   +2 more sources

Criteria for use of interferon alfa-2a or interferon alfa-2b for selected indications in adults.

American journal of hospital pharmacy, 1994
openaire   +3 more sources

Interferon alfa-NI.

2011
openaire   +1 more source

Interferon alfa-2a.

2011
openaire   +1 more source